Basic Information
| LncRNA/CircRNA Name | LINC00628 |
| Synonyms | NA |
| Region | GRCh38_1:204368431-204369719 |
| Ensemble | ENSG00000280924 |
| Refseq | NR_027022 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qPCR, Luciferase reporter assay |
| Sample | HCC tissues and cell lines |
| Expression Pattern | down-regulated |
| Function Description | Our investigation has revealed that LINC00628 were dramatically decreased in HCC tissues and cells, and inhibited the migration and invasion of HCC cells in vitro and in vivo. |
| Pubmed ID | 30740671 |
| Year | 2019 |
| Title | LINC00628 suppresses migration and invasion of hepatocellular carcinoma by its conserved region interacting with the promoter of VEGFA. |
External Links
| Links for LINC00628 | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |